BOCOM International
Search documents
2季度盈利在低基数上增长强劲,估值仍具回升空间
BOCOM International· 2025-07-18 08:41
Industry Rating - The report maintains a "Leading" investment rating for the securities industry, indicating strong growth potential and favorable market conditions [1]. Core Insights - The report highlights a robust growth in Q2 earnings for the securities industry, with a year-on-year profit increase of 65%-80% for A-share listed brokers, averaging 72% [4][5]. - The average daily trading volume in A-shares for H1 2025 reached 1.36 trillion RMB, reflecting a year-on-year growth of 58.8% [4]. - The report emphasizes that the current valuation of the securities sector remains attractive, with the A-share securities industry index trading at a price-to-book ratio of 1.38, below the historical median of 1.52 [4]. Valuation Summary - The report provides a detailed valuation overview for key companies in the securities sector, including: - CITIC Securities (6030 HK): Buy rating, target price of 30.00 HKD, current price 25.65 HKD, with a potential upside of 17.0% [2][17]. - Huatai Securities (6886 HK): Buy rating, target price of 20.00 HKD, current price 16.40 HKD, with a potential upside of 22.0% [2][31]. - CICC (3908 HK): Buy rating, target price of 22.00 HKD, current price 18.94 HKD, with a potential upside of 16.2% [2][17]. - CITIC Construction Investment (6066 HK): Buy rating, target price of 14.00 HKD, current price 11.80 HKD, with a potential upside of 18.6% [2][17]. Performance Trends - The report notes that the performance of the securities industry has significantly improved compared to the previous year, with major indices showing positive trends [3][12]. - The report indicates that the IPO fundraising in A-shares has seen a recovery, with a total of 374 million RMB raised in H1 2025, marking a 15% year-on-year increase [4][10]. Financial Forecasts - The report projects a 19% year-on-year growth in overall profits for the securities industry in 2025, driven by favorable market conditions and strong performance from leading brokers [4][19]. - Specific forecasts for CITIC Securities include a projected net profit of 25.8 billion RMB for 2025, reflecting an 18.9% increase from the previous year [21][28]. Conclusion - The report concludes that the securities industry is well-positioned for continued growth, supported by strong earnings, favorable market conditions, and attractive valuations, maintaining a positive outlook for key players in the sector [4][19].
中国生物制药(01177):5亿美元收购礼新医药带来差异化管线资产和技术平台,上调目标价
BOCOM International· 2025-07-18 07:36
Investment Rating - The report assigns a "Buy" rating to China Biologic Products (1177 HK) with a target price of HKD 8.00, indicating a potential upside of 17.3% from the current price of HKD 6.82 [4][10][15]. Core Insights - The acquisition of Lixin Pharmaceutical for USD 5 billion is expected to enhance the company's differentiated pipeline assets and technology platforms, leading to an upward revision of the target price [2][7]. - The integration of Lixin's four unique technology platforms is anticipated to accelerate the development of China Biologic's self-researched products, with significant potential contributions to revenue growth [7][10]. - The report highlights that Lixin has eight drug candidates in clinical stages, including promising candidates with licensing agreements worth up to USD 4 billion with major pharmaceutical companies [7][10]. Financial Overview - Revenue projections for China Biologic Products are as follows: - 2023: RMB 26,199 million - 2024: RMB 28,866 million - 2025E: RMB 34,175 million (growth of 18.4%) - 2026E: RMB 38,706 million (growth of 13.3%) - 2027E: RMB 43,606 million (growth of 12.7%) [3][16]. - Net profit estimates are projected to increase from RMB 2,332 million in 2023 to RMB 5,340 million by 2027, reflecting a significant growth trajectory [3][16]. - The report also notes an adjustment in the net profit forecast for 2025-2027, with an increase of 6-10% due to cost reduction efforts [7][9]. Valuation Model - The DCF valuation model estimates the equity value of China Biologic Products at HKD 8.00 per share, based on projected free cash flows and a perpetual growth rate of 2% [10][11]. - The enterprise value is calculated at RMB 152,132 million, with a net cash position of RMB 2,478 million [10][11]. Market Performance - The stock has shown a year-to-date increase of 113.13%, with a 52-week high of HKD 6.82 and a low of HKD 2.73 [6][10].
交银国际每日晨报-20250718
BOCOM International· 2025-07-18 02:13
Group 1: Company Overview - TSMC's management has raised its full-year revenue growth guidance from approximately 25% to 30% year-on-year, indicating strong resilience in gross margin at 58.6%, surpassing previous expectations [1][2] - The company anticipates that the demand for AI chips will increase due to the U.S. government's relaxation of export restrictions, which is expected to drive the demand for advanced process technologies [2] - TSMC plans to ramp up production of its 2nm process technology in the second half of 2025, with expectations that the volume of 2nm wafers will exceed that of 3nm and 5nm wafers during the same period [2] Group 2: Financial Projections - The target price for TSMC has been raised to $280, reflecting a potential upside of 17.9% from the closing price of $237.56, based on a 26x average P/E ratio for 2025/26 [1][2] - Adjustments to earnings per share (EPS) estimates have been made, with new projections set at 59.5 and 65.5 New Taiwan Dollars, down from previous estimates of 60.8 and 69.6 New Taiwan Dollars [2] Group 3: Market Context - The report highlights that the recovery in consumer electronics is expected to be moderate due to trade uncertainties, but the high demand for AI is likely to sustain TSMC's pricing for 3nm and 5nm technologies [2] - The global semiconductor market is projected to see 30% of its capacity in processes below 2nm being produced in the U.S. in the long term [2]
交银国际每日晨报-20250717
BOCOM International· 2025-07-17 01:19
Group 1: Anta Sports Products (2020 HK) - The second quarter revenue met expectations, with management reaffirming the annual guidance for 2025, indicating low single-digit, mid single-digit, and 50-55% year-on-year revenue growth for Anta, FILA, and other brands respectively [3] - Despite intense industry competition, management maintains growth guidance for all brands, expecting high single-digit, mid single-digit, and over 30% year-on-year growth for Anta, FILA, and other brands respectively [3] - The forecast for net profit from 2025 to 2027 is projected to be between RMB 13.41 billion and RMB 16.54 billion, with a target price of HKD 110.20 based on a 20x P/E ratio for 2026, maintaining a buy rating [3][4] Group 2: Junda Co., Ltd. (002865 CH) - The company expects a loss of RMB 0.94 billion to RMB 1.94 billion in Q2 2025, which is an increase from the loss of RMB 1.06 billion in Q1 2025, primarily due to a decline in battery prices following a surge in installations in mainland China [5] - Junda has signed a strategic cooperation agreement with Turkey and Europe's largest photovoltaic module manufacturer to jointly build a solar cell production base with a capacity of up to 5GW [5] - The outlook remains positive for the company, anticipating a turnaround in performance in 2026 driven by the commencement of production in Oman and supply-side reforms [5] Group 3: E-commerce Industry - In Q2 2025, adjusted year-on-year growth for physical e-commerce retail sales was 6.3%, with categories like home appliances and cosmetics experiencing a decline in growth [7] - E-commerce platforms are increasing investments in instant retail to drive cross-selling with traditional shelf e-commerce, enhancing user engagement [7] - Major players like Alibaba and JD.com are expected to maintain double-digit year-on-year growth, although profitability may be pressured due to increased investments in flash sales and delivery services [8] Group 4: Economic Data Insights - The consumer price index for June is expected to show a month-on-month increase of 0.30% in both the US and China, with the previous data being 0.10% [9] - The industrial product factory price index is anticipated to rise by 0.20% year-on-year in the US for June [9]
钧达股份(002865):产品价格偏软下业绩预告符合预期,海外产能布局再下一城
BOCOM International· 2025-07-16 12:29
Investment Rating - The investment rating for the company is "Buy" [2][8]. Core Insights - The company has released a performance forecast indicating a loss of 200-300 million RMB for 1H25, which aligns with market expectations due to a decline in battery prices following a surge in installations in mainland China [6]. - The company has signed a strategic cooperation agreement with Schmid Pekintaş Energy to establish a 5GW solar cell production base in Turkey, which is expected to enhance its overseas capacity and market presence [6]. - Recent government meetings suggest a potential turnaround in the solar supply side, with material prices beginning to recover [6]. Financial Overview - Revenue projections for the company are as follows: 2023: 18,657 million RMB, 2024: 9,952 million RMB, 2025E: 8,431 million RMB, 2026E: 13,874 million RMB, 2027E: 15,397 million RMB, with a significant year-on-year growth of 60.9% in 2023 followed by a decline in subsequent years [5][11]. - Net profit forecasts show a loss in 2024 and 2025E, with expected profits of 1,427 million RMB in 2026 and 1,726 million RMB in 2027 [5][11]. - The company's earnings per share (EPS) are projected to be 3.59 RMB in 2023, dropping to -2.58 RMB in 2024, and recovering to 4.88 RMB in 2026 and 5.90 RMB in 2027 [5][11]. Valuation Metrics - The target price for the company has been adjusted to 49.82 RMB, reflecting a 10.2x price-to-earnings ratio for 2026 [6][7]. - The company’s market capitalization is approximately 9,538.81 million RMB, with a 52-week high of 80.40 RMB and a low of 34.80 RMB [4][6]. Market Position - The company has a significant overseas revenue contribution, accounting for 51.9% in 1H25, although this is a decrease from 58% in 1Q25 [6]. - The strategic move to establish a production base in Turkey is aimed at capturing local market opportunities and facilitating exports to higher-priced markets like the USA [6].
互联网行业月报:2季度电商加速增长,即时零售为投入主题-20250716
BOCOM International· 2025-07-16 09:51
Investment Rating - The report assigns a "Buy" rating to major companies in the e-commerce sector, including Alibaba, JD.com, Pinduoduo, and Kuaishou [2][3]. Core Insights - The e-commerce industry is experiencing accelerated growth in Q2 2025, with online retail sales of physical goods showing a year-on-year increase of 6.3%, up from 5.7% in Q1 [1][3]. - Instant retail is a key investment theme, with major platforms increasing their investments to drive high-frequency consumption and cross-selling opportunities [3]. - The report anticipates continued growth trends in the industry, with specific expectations for Alibaba, JD.com, Pinduoduo, and Kuaishou regarding their performance and profitability [3]. Summary by Sections E-commerce Growth - In Q2 2025, the online retail sales of physical goods are projected to maintain a year-on-year double-digit growth, benefiting from improved penetration and technology service fees [3]. - The report highlights that the demand for home decoration is recovering, with furniture sales growing by 29% year-on-year [1]. Company Performance - Alibaba's daily peak orders for its flash purchase service exceeded 80 million, with a DAU surpassing 200 million, reflecting a week-on-week growth of 15% [3]. - JD.com reported that nearly 200 restaurant brands achieved sales of over one million, launching a "Double Hundred Plan" to support more brands [3]. - Pinduoduo plans to launch instant delivery services in select first-tier cities, focusing on high-frequency categories like fresh produce and fast-moving consumer goods [3]. Market Outlook - The report projects that the overall e-commerce market GMV will grow by 5% year-on-year in 2025 [11]. - The logistics sector is also expected to see growth, with the postal bureau estimating a 19% year-on-year increase in express delivery volume for the first half of 2025 [9].
交银国际每日晨报-20250716
BOCOM International· 2025-07-16 09:39
Group 1: Macroeconomic Overview - China's GDP growth for the first half of 2025 is 5.3% year-on-year, with a slight slowdown in Q2 to 5.2% compared to 5.4% in Q1, indicating resilience amid global economic disruptions [3][4] - The contribution from consumption, investment, and net exports improved in Q2, with consumption at 52.3%, investment at 24.7%, and net exports at 23%, showing better internal demand coordination [3] - Industrial production accelerated to 6.8% in June, while consumption growth slowed to 4.8%, reflecting short-term disturbances affecting economic trends [3][4] Group 2: Pharmaceutical Industry Insights - The valuation of Hong Kong's innovative pharmaceutical sector remains attractive, with leading companies' forward price-to-sales ratios aligning with historical averages, despite being slightly higher than comparable US firms [5] - Domestic capital continues to increase holdings in Hong Kong stocks, while foreign investment in innovative pharmaceuticals is at a low point, indicating potential for future growth [5] - The upcoming commercial insurance innovative drug directory is expected to create a more favorable pricing environment, potentially leading to significant growth in premium and payment scales for innovative drugs [7] Group 3: Company-Specific Analysis - Li Ning's Q2 sales growth was below expectations, with a low single-digit increase in retail revenue, indicating a weakening recovery trend compared to Q1 [8][9] - JD's Q2 losses from its food delivery segment are expected to significantly impact overall profits, with a projected 60% year-on-year decline in profits, although retail performance remains stable [10] - Adjustments to Li Ning's revenue forecasts for 2025-2027 reflect a cautious outlook, with expected revenues revised down by 0.3-5.8% to between 29.0-30.95 billion RMB [9]
安踏体育(02020):安踏(2020HK)
BOCOM International· 2025-07-16 09:32
Investment Rating - The report assigns a "Buy" rating for the company, Anta (2020 HK), with a target price of HKD 110.20, indicating a potential upside of 22.7% from the current price of HKD 89.80 [1][2][15]. Core Insights - The company's second-quarter revenue met expectations, with management reaffirming the annual guidance for growth across its brands, despite a competitive industry landscape. The expected revenue growth for Anta, FILA, and other brands is high single digits, mid single digits, and over 30% respectively [6][7]. - The report maintains revenue forecasts for the next three years but slightly lowers profit margin expectations due to industry discount pressures. Projected net profits for 2025-2027 are estimated to be between RMB 134.1 billion and RMB 165.4 billion [6][7]. - Anta's brand sales momentum has slightly slowed, but improvements in online channels are anticipated in the second half of the year. The company is optimizing its offline store strategy and expects to maintain high single-digit growth for the Anta brand [6][7]. Financial Overview - Revenue projections for the company are as follows: RMB 62,356 million in 2023, RMB 70,826 million in 2024, RMB 77,140 million in 2025, RMB 83,936 million in 2026, and RMB 90,550 million in 2027, with year-on-year growth rates of 16.2%, 13.6%, 8.9%, 8.8%, and 7.9% respectively [5][8][16]. - The net profit forecast for the same years is RMB 10,236 million in 2023, RMB 15,596 million in 2024, RMB 13,410 million in 2025, RMB 15,021 million in 2026, and RMB 16,543 million in 2027, with corresponding growth rates of 30.8%, 50.3%, -14.0%, 12.4%, and 10.1% [5][8][16]. - The report highlights a projected decline in profit margins, with gross profit margins expected to be 62.0% in 2025, 62.1% in 2026, and 62.2% in 2027 [7][17]. Brand Performance - Anta's brand recorded low single-digit revenue growth in the second quarter, while FILA achieved mid single-digit growth. Other brands like Descente and KOLON saw high growth rates of over 40% and 70% respectively [6][7]. - The inventory turnover ratio for FILA improved to five months, and the company strategically increased discounts in the e-commerce channel to optimize inventory [6][7].
上半年新旧动能加速切换,内外需平衡改善
BOCOM International· 2025-07-16 06:53
Macroeconomic Overview - In the first half of 2025, China's GDP grew by 5.3% year-on-year, with a slight slowdown in Q2 at 5.2% compared to 5.4% in Q1, indicating a stable economic performance amidst global economic uncertainties [1][9] - The contribution of consumption, investment, and net exports to growth improved in Q2, with consumption at 52.3%, investment at 24.7%, and net exports at 23.0%, highlighting a better balance between internal and external demand [1][2] Industrial Production - The industrial added value for large-scale industries increased by 6.4% year-on-year in the first half of 2025, with June's growth accelerating to 6.8% [2][16] - Manufacturing output grew by 7.0%, with equipment manufacturing and high-tech manufacturing showing significant growth rates of 10.2% and 9.5%, respectively [2][16] - New energy vehicles and industrial robots saw production increases of 36.2% and 35.6%, respectively, reflecting a trend towards high-end and intelligent manufacturing [2][16] Consumer Market - Retail sales of consumer goods increased by 5.0% year-on-year in the first half of 2025, with a notable acceleration in Q2 [3][16] - The "old-for-new" policy positively impacted sales in categories such as home appliances and communication equipment, with growth rates of 30.7% and 24.1%, respectively [3][16] - Service consumption also showed recovery, with service retail sales growing by 5.3% [3][16] Investment Trends - Fixed asset investment grew by 2.8% year-on-year in the first half of 2025, with manufacturing investment increasing by 7.5% [5][16] - Infrastructure investment rose by 4.6%, while private investment saw a decline of 0.6%, although other private investments excluding real estate grew by 5.1% [5][16] - Investment growth volatility is attributed to fluctuating upstream material prices and reduced capacity utilization in traditional sectors [5][16] Real Estate Market - New housing sales in the first half of 2025 decreased by 3.5% in area and 5.5% in value, although the decline rate narrowed compared to the previous year [6][16] - In June, housing prices in major cities showed a downward trend, with new residential prices in first-tier cities decreasing by 0.3% [6][16] - The government is expected to implement stronger measures to stabilize the real estate market, with policies aimed at boosting demand and supporting housing construction [6][16] Foreign Trade - Total goods imports and exports increased by 2.9% year-on-year in the first half of 2025, with exports rising by 7.2% and imports falling by 2.7% [7][16] - The export of mechanical and electrical products grew by 9.5%, accounting for 60.0% of total exports, indicating a diversification of trade partners and resilience in external trade [7][16] - Trade with countries along the "Belt and Road" increased by 4.7%, providing a buffer against fluctuations in traditional markets [7][16] Financial Sector - The total social financing scale increased by 22.83 trillion yuan in the first half of 2025, with June's new social financing reaching 4.2 trillion yuan [8][16] - The M2 money supply grew by 8.3% year-on-year, indicating improved liquidity and funding support for the real economy [8][16] - The structure of credit also showed positive changes, with stable growth in household loans and a rebound in medium to long-term loans for enterprises [8][16]
李宁(02331):2季度流水缓慢恢复,不确定性仍存
BOCOM International· 2025-07-15 08:17
Investment Rating - The report assigns a "Neutral" rating to the company, Li Ning (2331 HK), with a target price of HKD 16.28, indicating a potential upside of 1.4% from the current price of HKD 16.06 [1][2][5]. Core Insights - The second quarter saw a slow recovery in sales, slightly below the company's expectations, with retail sales growth in the Li Ning brand (excluding Li Ning YOUNG) showing low single-digit year-on-year growth [5][6]. - The management indicated that the recovery trend in Q2 weakened compared to Q1, and sales and discounts remain under pressure since July [5]. - The report suggests that the company's sales recovery in the second half of the year will be gradual, leading to a downward revision of net profit forecasts for 2025-2027 [5][6]. Financial Overview - Revenue projections for 2025 are set at RMB 29,007 million, reflecting a year-on-year growth of 1.2%. The revenue for 2026 and 2027 is projected to be RMB 30,103 million and RMB 30,945 million, respectively [4][8]. - Net profit estimates for 2025 have been revised down to RMB 2,678 million, with a projected decline in net profit margins due to increased promotional activities and competition [5][7]. - The report anticipates a slight decrease in gross margin for 2025, with a forecasted gross margin of 49.1% [7][8]. Sales Channel Performance - In Q2, online sales outperformed offline channels, with e-commerce showing mid-single-digit growth year-on-year, while offline retail experienced low single-digit declines [5][6]. - The wholesale channel performed better than retail, with low single-digit growth in wholesale and a decline in retail sales [5][6]. Store Optimization and Product Trends - The number of offline stores is undergoing slight adjustments, with a net increase of 11 stores compared to Q1, while Li Ning YOUNG saw a net decrease of 18 stores [6][8]. - Product category growth continued from Q1, with running and fitness categories leading, while basketball products faced significant declines [6][8].